Baxano Surgical, Inc. Announces Participation in JMP Securities Healthcare Conference

RALEIGH, N.C., June 25, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it will participate in the JMP Securities Healthcare Conference in July.

Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the JMP Securities Healthcare Conference in New York, NY on Tuesday, July 9, 2013 at 9:30 am EDT.

Institutional investors that wish to request a meeting with Baxano Surgical should contact JMP Securities.

About Baxano Surgical, Inc.

Baxano Surgical, Inc. is a medical device company focused on designing, developing, and marketing products to treat degenerative conditions of the spine affecting the lumbar region. Baxano Surgical currently markets the AxiaLIF® family of products for single and two level lumbar fusion, the VEOTM lateral access and interbody fusion system, and the iO-Flex® system, a proprietary minimally invasive set of flexible instruments allowing surgeons to target lumbar spinal stenosis during spinal decompression procedures in all three regions of the spine: central canal, lateral recess and neural foramen. Baxano Surgical was founded in May 2000 and is headquartered in Raleigh, North Carolina. For more information, visit

CONTACT: Investors: Baxano Surgical, Inc. Joseph P. Slattery, 866-256-1206 Executive Vice President and Chief Financial Officer Westwicke Partners Mark Klausner, 443-213-0501 baxano@westwicke.comSource:Baxano Surgical, Inc.